Photo from www.thespruce.com

 

The new syrup form of Favipiravir antiviral COVID-19 medication, developed by Chulabhorn Royal Academy (CRA), Chulalongkorn University’s Faculty of Pharmaceutical Sciences and Thai research organization Medica Innova, will be available for infected children and the elderly for free at Chulabhorn Hospital in Bangkok from this Friday (August 6th).

 

The sugar-free, orange-coloured and raspberry-flavoured syrup will be given to no more than 100 COVID-19 patients per week and is only available on prescription. The focus will be on children, people aged 70 and over and others who have difficulty swallowing tablets, according to CRA Secretary-General Dr. Nithi Mahanonda yesterday (Tuesday).

 

The dose is either 800mg/60ml or 1,800mg/135ml. It is to be taken twice a day, with an interval of 12 hours. For children, on the first day, 60mg/kg is to be taken twice. On the following days, 20mg/kg is to be taken twice per day. For adults, on the first day, 1,800mg is to be taken twice. On the following days, 800mg is to be taken twice a day. For those weighing over 90kgs, or with a high BMI, 2,400mg is to be taken twice on the first day, and 1,000mg dosages to be taken twice a day on the following days.

 

Full Story: https://www.thaipbsworld.com/thailands-newly-developed-favipiravir-syrup-to-be-given-to-children-elderly-from-friday/

 

-- © Copyright Thai PBS 2021-08-04

 

- Whatever you're going through, the Samaritans are here for you

- Follow ASEAN NOW on LINE for breaking COVID-19 updates

While the international jury may still be out over the validity of Favipiravir the confidence imbued even  by way of a placebo effect can be considered beneficial at very least so long as it is not promoted as a primary solution to Covid-19.

100 patients per week, when there are 20k infected daily, is only for propaganda purpose, that this royal academy is helping at all

Mmm kool aid !! ????

In desperate times normally rational people lose it.

 

Filing this in that category.

 

Thank goodness it's only 100 people.

 

 

Does it taste good?

 

That seems to be the only relevant question. I'll leave it there.

Well done, Thailand...I remember, was it Zanzibar or Madagascar, who were fighting Covid with some miracle drinks?

 

 

13 hours ago, snoop1130 said:

no more than 100 COVID-19 patients per week

It's like trying to squeeze water out of a rock, isn't it?
Is there really nobody with a working brain screwed on in this administration?

This scientific study shows that the mortality rate for Favipiravir treated patients is 30% less than patients not treated with Favipiravir, when treating already infected Covid-19 patients. It also suggest that using it as a preventive (before infection) may be more effective: https://www.nature.com/articles/s41598-021-90551-6

 

Favi Piravi , sound like an Indian rap singer.

Again with the Bangkok first fanfare.  I'd take this, living in Pattaya where there are no vaccines for farangs.

11 hours ago, internationalism said:

100 patients per week, when there are 20k infected daily, is only for propaganda purpose, that this royal academy is helping at all

Perhaps so. But also perhaps this syrup form is at low production because it is usually dispensed in tablet form that is more available . Invented/created in Japan it has been quite extensively used to treat immune resistance in influenza cases and experimentally  for Ebola and other situations.

It has a positive reputation as a pre symptomatic therapy shown to lessen development of RNA viral infection.

2 hours ago, AlQaholic said:

This scientific study shows that the mortality rate for Favipiravir treated patients is 30% less than patients not treated with Favipiravir, when treating already infected Covid-19 patients. It also suggest that using it as a preventive (before infection) may be more effective: https://www.nature.com/articles/s41598-021-90551-6

 

You forgot to mention that the SAME article also said "this finding not statistically significant". and "Favipiravir possibly exerted no significant beneficial effect in the term of mortality in the general group of patients with mild to moderate COVID-19. We should consider that perhaps the use of antiviral once the patient has symptoms is too late and this would explain their low efficacy in the clinical setting". 

yes, very low production.

but if tens of scientists from Chulabhorn Royal Academy (CRA), Chulalongkorn University’s Faculty of Pharmaceutical Sciences and Thai research organization Medica Innova worked on it and their capital and capacity is big, why only so small?

That is token help.

Do compare 3mln monthly made by the PGO now (with a prospect 40mln from October), to 3k by royal academy. 

Edited August 5, 20214 yr by internationalism

Well done Thailand.

 

Guess it could be the All Round medication while going into space.

 

Administered with some TC sausages (yak), might be a good idea for this lot to become the space medical center.

 

A little off topic,sorry.

 

 

1 hour ago, Seismic said:

"this finding not statistically significant"

 

True believers find statements like these in "studies" as best left unread.

 

Favipiravir is the basis of the treatment regimen here, used in Mild cases in high risk groups, and in pneumonia cases.

 

Obviously useless, but I guess it makes them feel like they're doing something? On the plus side, they're not using Clorox.

 

Pneumonia case recommend three drugs combination including of
• Chloroquine (500-1000 mg) per day
• Favipiravir (200 mg) 8 tablets two times on Day1 then 3 tablets two times per day from Day 2-10 or Favipiravir 60 mg/kg of bodyweight (in patient with BMI ≥35 kg/m2).
• Lopinavir/Ritonavir (400/100) two times per day or alternative regimens Darunavir/Ritonavir (900/100) once daily or Darunavir/Ritonavir (600/100) two times per day.

Two posts with links to Bangkok Post removed

 

26) The Bangkok Post and Phuketwan do not allow quotes from their news articles or other material to appear on ASEANNOW.com. Neither do they allow links to their publications. Posts from members containing quotes from or links to Bangkok Post or Phuketwan publications will be deleted from the forum.

3 hours ago, Seismic said:

You forgot to mention that the SAME article also said "this finding not statistically significant". and "Favipiravir possibly exerted no significant beneficial effect in the term of mortality in the general group of patients with mild to moderate COVID-19. We should consider that perhaps the use of antiviral once the patient has symptoms is too late and this would explain their low efficacy in the clinical setting". 

That's what I meant, couldn't have said it better, thanks!